[Finding the right platelet anti-aggregant prescription for type-2 diabetes patients, according to the ADA 2003 criteria].
作者信息
Raméntol Teys Sandra, Pujol Blaya Vicenta, León de la Fuente Mónica, León-Sanromà María
机构信息
EAP La Gavarra, Institut Català de la Salut, SAP Baix Llobregat Centre, Unidad Docente de Medicina Familiar y Comunitaria Costa de Ponent, Cornellà de Llobregat, Barcelona, España.
出版信息
Aten Primaria. 2006 Oct 31;38(7):413. doi: 10.1016/s0212-6567(06)70535-2.
Abstract
摘要
相似文献
1
[Finding the right platelet anti-aggregant prescription for type-2 diabetes patients, according to the ADA 2003 criteria].
Aten Primaria. 2006 Oct 31;38(7):413. doi: 10.1016/s0212-6567(06)70535-2.
2
[Primary prevention with aspirin for cardiovascular diseases in diabetic patients. What evidence supports the criteria of the ADA?].
Aten Primaria. 2007 Mar;39(3):163-4. doi: 10.1016/s0212-6567(07)70867-3.
3
Does aspirin use reduce cardiovascular risk in diabetes?
Nat Rev Endocrinol. 2009 Apr;5(4):188-90. doi: 10.1038/nrendo.2009.44.
4
[Acetylsalicylic acid in patients with diabetes for the primary prevention of cardiovascular disease].
Ned Tijdschr Geneeskd. 2004 Oct 16;148(42):2097; author reply 2097-8.
5
Aspirin for primary prevention of cardiovascular events in diabetes: still an open question.
JAMA. 2008 Nov 12;300(18):2180-1. doi: 10.1001/jama.2008.625. Epub 2008 Nov 9.
6
Use of antiplatelet therapy in a diabetic outpatient service of a large urban public hospital.
Nutr Metab Cardiovasc Dis. 2005 Feb;15(1):42-6. doi: 10.1016/j.numecd.2004.04.001.
7
[Use of aspirin for primary prevention of cardiovascular events in diabetic patients--is it justified?].
Rev Med Interne. 2009 Dec;30(12):1001-3. doi: 10.1016/j.revmed.2009.08.003. Epub 2009 Oct 14.
8
Aspirin therapy is still underutilized among patients with type 2 diabetes.
Arq Bras Endocrinol Metabol. 2006 Dec;50(6):1014-9. doi: 10.1590/s0004-27302006000600006.
9
Aspirin in the treatment of type 2 diabetes.
Arch Intern Med. 2000 Feb 14;160(3):394. doi: 10.1001/archinte.160.3.394.
10
Appropriate aspirin use for primary prevention of cardiovascular disease.
Am Fam Physician. 2011 Jun 15;83(12):1380-6.
引用本文的文献
1
[Primary prevention with aspirin for cardiovascular diseases in diabetic patients. What evidence supports the criteria of the ADA?].
Aten Primaria. 2007 Mar;39(3):163-4. doi: 10.1016/s0212-6567(07)70867-3.
本文引用的文献
1
Community pharmacy Target Intervention Program to improve aspirin use in persons with diabetes.
J Am Pharm Assoc (2003). 2005 Jan-Feb;45(1):17-22. doi: 10.1331/1544345052843020.
2
Aspirin use among adults with diabetes: recent trends and emerging sex disparities.
Arch Intern Med. 2004;164(22):2492-9. doi: 10.1001/archinte.164.22.2492.
3
[Acetylsalicylic acid consumption in patients with diabetes mellitus].
Med Clin (Barc). 2004 Jan 31;122(3):96-8. doi: 10.1016/s0025-7753(04)74155-x.
4
Why are eligible patients not prescribed aspirin in primary care? A qualitative study indicating measures for improvement.
BMC Fam Pract. 2003 Jul 18;4:9. doi: 10.1186/1471-2296-4-9.
5
[Use of anti-aggregant drugs in primary and secondary cardiovascular prevention in diabetics in town and country in the León area].
Aten Primaria. 2003;31(6):361-5. doi: 10.1016/s0212-6567(03)70699-4.
6
Aspirin therapy in diabetes.
Diabetes Care. 2003 Jan;26 Suppl 1:S87-8. doi: 10.2337/diacare.26.2007.s87.
Zotero 插件